


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:03:20Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405725" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405725</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>frontimmu</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="correction" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405725</article-id><article-id pub-id-type="pmcid-ver">PMC12405725.1</article-id><article-id pub-id-type="pmcaid">12405725</article-id><article-id pub-id-type="pmcaiid">12405725</article-id><article-id pub-id-type="pmid">40909288</article-id><article-id pub-id-type="doi">10.3389/fimmu.2025.1682368</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Correction</subject></subj-group></subj-group></article-categories><title-group><article-title>Correction: The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><collab>Frontiers Production Office</collab><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/20170/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib></contrib-group><aff id="aff1">
<institution>Frontiers Media SA</institution>, <addr-line>Lausanne</addr-line>,&#160;<country>Switzerland</country>
</aff><author-notes><fn fn-type="edited-by"><p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p></fn><corresp id="fn001">*Correspondence: Frontiers Production Office, <email xlink:href="mailto:mailto:production.office@frontiersin.org">mailto:production.office@frontiersin.org</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><issue-id pub-id-type="pmc-issue-id">480569</issue-id><elocation-id>1682368</elocation-id><history><date date-type="received"><day>08</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>08</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>20</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-05 09:25:55.133"><day>05</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 Frontiers Production Office.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Frontiers Production Office</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="fimmu-16-1682368.pdf"/><related-article related-article-type="corrected-article" xml:lang="en" xlink:title="research-article" journal-id="Front Immunol" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC12355927"><article-title>The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases</article-title><volume>16</volume><date><day>1</day><month>8</month><year>2025</year></date><elocation-id>1624095</elocation-id><source>Frontiers in Immunology</source><pub-id pub-id-type="doi">10.3389/fimmu.2025.1624095</pub-id><pub-id pub-id-type="pmcid">PMC12355927</pub-id><pub-id pub-id-type="pmid">40821798</pub-id></related-article><kwd-group><kwd>chronic disease</kwd><kwd>inactivated quadrivalent influenza vaccine</kwd><kwd>23-valent pneumococcal polysaccharide vaccine</kwd><kwd>simultaneous administration</kwd><kwd>immunogenicity</kwd><kwd>safety</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><equation-count count="0"/><ref-count count="0"/><page-count count="1"/><word-count count="30"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Vaccines and Molecular Therapeutics</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>The Reviewer Ahmed Tawfik Moustafa&#8217;s affiliation &#8220;Institut Pasteur de Paris, France&#8221; was erroneously given as &#8220;Institut Pasteur de Lille, France&#8221;.</p><p>The original version of this article has been updated.</p></body></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>